Identification of EBV epitope-specific T cell receptors for adoptive T cell transfer against EBV infection and associated malignancies

被引：0
|
作者：
Cobo, Lammoglia M. F. [1 ]
Welters, C. [1 ]
Pircher, C. [2 ]
Gary, R. [3 ]
Dietze, K. [1 ]
Takvorian, A. [1 ]
Penter, L. [1 ]
Bullinger, L. [1 ]
Dornmair, K. [4 ]
Moosmann, A. [5 ]
Mautner, J. [5 ]
Blankenstein, T. [2 ,6 ]
Kammertoens, T. [2 ]
Gerbitz, A. [7 ]
Hansmann, L. [1 ]
机构：
[1] Charite Univ Med Berlin, Dept Hematol Oncol & Tumor Immunol, Berlin, Germany
[2] Charite Univ Med Berlin, Inst Immunol, Berlin, Germany
[3] Univ Med Erlangen, Inst Hematol & Oncol, Erlangen, Germany
[4] Ludwig Maximilian Univ Munich, Inst Clin Neuroimmunol, Munich, Germany
[5] Helmholtz Ctr Munich, Res Unit Gene Vectors, Munich, Germany
[6] Max Delbruck Ctr Mol Med, Berlin, Germany
[7] Princess Margaret Canc Ctr, Hans Messner Allogene Stem Cell Transplant Progra, Toronto, ON, Canada
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2020年 / 43卷 / SUPPL 4期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
400
引用
收藏
页码：239 / 239
页数：1
相关论文
共 50 条
  • [1] Single cell identification of defined ebv epitope-specific TCRαβ pairs for adoptive T cell transfer against EBV infection and EBV-associated malignancies
    Cobo, Maria Fernanda Lammoglia
    Pircher, Christian
    Dietze, Kerstin
    Kammertons, Thomas
    Gary, Regina
    Moosmann, Andreas
    Mautner, Josef
    Dornmair, Klaus
    Takvorian, Anna
    Bullinger, Lars
    Blankenstein, Thomas
    Gerbitz, Armin
    Hansmann, Leo
    BONE MARROW TRANSPLANTATION, 2019, 54 : 177 - 178
  • [2] Adoptive immunotherapy of EBV-associated malignancies with EBV-specific cytotoxic T-cell lines
    Rooney, CM
    Aguilar, LK
    Huls, MH
    Brenner, MK
    Heslop, HE
    EPSTEIN-BARR VIRUS AND HUMAN CANCER, 2001, 258 : 221 - 229
  • [3] Adoptive transfer of polyclonal, EBV-specific cytotoxic T-cell lines for the prevention and treatment of EBV-associated malignancies
    Rooney, CM
    Huls, MH
    Rochester, RA
    Brenner, MK
    Heslop, HE
    CELL THERAPY, 2000, 5 : 45 - 60
  • [4] Differential evolution and stability of epitope-specific CD8+ T cell responses in EBV infection
    Catalina, MD
    Sullivan, JL
    Bak, KR
    Luzuriaga, K
    JOURNAL OF IMMUNOLOGY, 2001, 167 (08): : 4450 - 4457
  • [5] T cell therapies for EBV associated malignancies
    Brenner, M
    JOURNAL OF IMMUNOTHERAPY, 2003, 26 (06): : S18 - S18
  • [6] Adoptive Transfer of EBV Specific CD8+ T Cell Clones Can Transiently Control EBV Infection in Humanized Mice
    Antsiferova, Olga
    Mueller, Anne
    Raemer, Patrick C.
    Chijioke, Obinna
    Chatterjee, Bithi
    Raykova, Ana
    Planas, Raquel
    Sospedra, Mireia
    Shumilov, Anatoliy
    Tsai, Ming-Han
    Delecluse, Henri-Jacques
    Muenz, Christian
    PLOS PATHOGENS, 2014, 10 (08)
  • [7] T-cell therapies for EBV-associated malignancies
    Brenner, MK
    Bollard, C
    Huls, MH
    Gottschalk, S
    Heslop, HE
    Rooney, CM
    REGENERATIVE AND CELL THERAPY: CLINICAL ADVANCES, 2005, (11): : 121 - 130
  • [8] Adoptive immunotherapy of malignancies with gene modified, EBV-specific, cytotoxic T-cell lines
    Brenner, Malcohn K.
    JOURNAL OF IMMUNOTHERAPY, 2007, 30 (08) : 888 - 888
  • [9] EBV-specific T-cell lines for adoptive transfer to PMRD allograft recipients
    Johnson, KJ
    Mostafa, BT
    Szmania, SM
    Godder, K
    Chiang, KY
    Henslee-Downey, PJ
    van Rhee, F
    EXPERIMENTAL HEMATOLOGY, 2000, 28 (07) : 57 - 57
  • [10] Eliciting protective T cell immunity against EBV-associated malignancies by vaccination
    Ruhl, J.
    Citterio, C.
    Leung, C.
    Munz, C.
    EUROPEAN JOURNAL OF CANCER, 2018, 92 : S19 - S19
12345